SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-007461
Filing Date
2021-03-31
Accepted
2021-03-31 16:16:03
Documents
75
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1899916
2 ex21-1.htm EX-21.1 2863
3 ex23-1.htm EX-23.1 3737
4 ex31.htm EX-31 31590
5 ex32.htm EX-32 7965
6 img_001.jpg GRAPHIC 17116
7 img_002.jpg GRAPHIC 16743
8 img_003.jpg GRAPHIC 15786
9 img_004.jpg GRAPHIC 469256
10 img_005.jpg GRAPHIC 8426
11 img_006.jpg GRAPHIC 22590
12 img_007.jpg GRAPHIC 24750
13 img_008.jpg GRAPHIC 16724
  Complete submission text file 0001493152-21-007461.txt   6655569

Data Files

Seq Description Document Type Size
14 XBRL INSTANCE FILE age-20201231.xml EX-101.INS 724190
15 XBRL SCHEMA FILE age-20201231.xsd EX-101.SCH 48073
16 XBRL CALCULATION FILE age-20201231_cal.xml EX-101.CAL 71100
17 XBRL DEFINITION FILE age-20201231_def.xml EX-101.DEF 246804
18 XBRL LABEL FILE age-20201231_lab.xml EX-101.LAB 398181
19 XBRL PRESENTATION FILE age-20201231_pre.xml EX-101.PRE 337756
Mailing Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501
Business Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38519 | Film No.: 21793516
SIC: 2834 Pharmaceutical Preparations